In the subjects for whom samples collected prior to the onset of COVID-19 were available, the serum ATX levels measured on day 9 − 10, day 11 − 12 and day 13 − 14 were significantly lower as compared to the values measured prior to the onset of COVID-19 (Figure 1(C)). This evidence concerns the gene ENPP2 and COVID-19.